249 related articles for article (PubMed ID: 15897571)
1. Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer.
Sato M; Johnson M; Zhang L; Gambhir SS; Carey M; Wu L
Clin Cancer Res; 2005 May; 11(10):3743-9. PubMed ID: 15897571
[TBL] [Abstract][Full Text] [Related]
2. Configurations of a two-tiered amplified gene expression system in adenoviral vectors designed to improve the specificity of in vivo prostate cancer imaging.
Sato M; Figueiredo ML; Burton JB; Johnson M; Chen M; Powell R; Gambhir SS; Carey M; Wu L
Gene Ther; 2008 Apr; 15(8):583-93. PubMed ID: 18305574
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth.
Mashima T; Okabe S; Seimiya H
Mol Pharmacol; 2010 Nov; 78(5):846-54. PubMed ID: 20709811
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector.
Iyer M; Salazar FB; Lewis X; Zhang L; Carey M; Wu L; Gambhir SS
Mol Ther; 2004 Sep; 10(3):545-52. PubMed ID: 15336654
[TBL] [Abstract][Full Text] [Related]
5. Androgen-independent molecular imaging vectors to detect castration-resistant and metastatic prostate cancer.
Jiang ZK; Sato M; Wei LH; Kao C; Wu L
Cancer Res; 2011 Oct; 71(19):6250-60. PubMed ID: 21933883
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of the partial androgen receptor enhances the efficacy of prostate-specific antigen promoter-driven suicide gene therapy for prostate cancer cells at low testosterone concentrations.
Suzuki S; Tadakuma T; Asano T; Hayakawa M
Cancer Res; 2001 Feb; 61(4):1276-9. PubMed ID: 11245419
[TBL] [Abstract][Full Text] [Related]
7. Interrogating androgen receptor function in recurrent prostate cancer.
Zhang L; Johnson M; Le KH; Sato M; Ilagan R; Iyer M; Gambhir SS; Wu L; Carey M
Cancer Res; 2003 Aug; 63(15):4552-60. PubMed ID: 12907631
[TBL] [Abstract][Full Text] [Related]
8. Unexpected paracrine action of prostate cancer cells harboring a new class of androgen receptor mutation--a new paradigm for cooperation among prostate tumor cells.
Lapouge G; Erdmann E; Marcias G; Jagla M; Monge A; Kessler P; Serra S; Lang H; Jacqmin D; Bergerat JP; Céraline J
Int J Cancer; 2007 Sep; 121(6):1238-44. PubMed ID: 17534890
[TBL] [Abstract][Full Text] [Related]
9. Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer.
Brown RS; Edwards J; Dogan A; Payne H; Harland SJ; Bartlett JM; Masters JR
J Pathol; 2002 Oct; 198(2):237-44. PubMed ID: 12237884
[TBL] [Abstract][Full Text] [Related]
10. Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.
Linja MJ; Savinainen KJ; Saramäki OR; Tammela TL; Vessella RL; Visakorpi T
Cancer Res; 2001 May; 61(9):3550-5. PubMed ID: 11325816
[TBL] [Abstract][Full Text] [Related]
11. Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy.
Sato M; Johnson M; Zhang L; Zhang B; Le K; Gambhir SS; Carey M; Wu L
Mol Ther; 2003 Nov; 8(5):726-37. PubMed ID: 14599805
[TBL] [Abstract][Full Text] [Related]
12. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
Sadar MD; Gleave ME
Cancer Res; 2000 Oct; 60(20):5825-31. PubMed ID: 11059779
[TBL] [Abstract][Full Text] [Related]
13. Two-step transcriptional amplification-lipid-based nanoparticles using PSMA or midkine promoter for suicide gene therapy in prostate cancer.
Hattori Y; Maitani Y
Cancer Sci; 2006 Aug; 97(8):787-98. PubMed ID: 16800821
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral versus intravenous gene therapy using a transcriptionally targeted viral vector in an orthotopic hepatocellular carcinoma rat model.
Kim YI; Ahn BC; Ronald JA; Katzenberg R; Singh A; Paulmurugan R; Ray S; Gambhir SS; Hofmann LV
J Vasc Interv Radiol; 2012 May; 23(5):704-11. PubMed ID: 22387029
[TBL] [Abstract][Full Text] [Related]
15. Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter-Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth.
Sung SY; Chang JL; Chen KC; Yeh SD; Liu YR; Su YH; Hsueh CY; Chung LW; Hsieh CL
PLoS One; 2016; 11(4):e0153350. PubMed ID: 27054343
[TBL] [Abstract][Full Text] [Related]
16. Two-step amplification of the human PPT sequence provides specific gene expression in an immunocompetent murine prostate cancer model.
Dzojic H; Cheng WS; Essand M
Cancer Gene Ther; 2007 Mar; 14(3):233-40. PubMed ID: 17053814
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
18. Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors.
Wu L; Matherly J; Smallwood A; Adams JY; Billick E; Belldegrun A; Carey M
Gene Ther; 2001 Sep; 8(18):1416-26. PubMed ID: 11571582
[TBL] [Abstract][Full Text] [Related]
19. Advanced two-step transcriptional amplification as a novel method for cancer-specific gene expression and imaging.
Watanabe M; Ueki H; Ochiai K; Huang P; Kobayashi Y; Nasu Y; Sasaki K; Kaku H; Kashiwakura Y; Kumon H
Oncol Rep; 2011 Oct; 26(4):769-75. PubMed ID: 21725614
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
